歡迎光臨源葉生物,登錄 | 注冊 |
當前位置: 首頁 > 小分子抑制劑 > CellCycle/Checkpoint > LEE011 Succinate

瀏覽歷史

S83037

LEE011 Succinate

源葉(MedMol) ≥98%
  • 英文名:
  • LEE011 Succinate
  • 別名:
  • CAS號:
  • 1374639-75-4
  • 分子式:
  • C27H36N8O5
  • 分子量:
  • 552.63
品牌貨號產(chǎn)品規(guī)格價格(RMB) 庫存(上海) 北京 武漢 南京 數(shù)量計量單位 加入購物車...
源葉(MedMol) S83037-5mg ≥98% ¥247.00元 10 - - - EA 加入購物車
源葉(MedMol) S83037-10mg ≥98% ¥370.00元 10 - - - EA 加入購物車
源葉(MedMol) S83037-25mg ≥98% ¥740.00元 10 - - - EA 加入購物車
源葉(MedMol) S83037-100mg ≥98% ¥1790.00元 6 - - - EA 加入購物車
源葉(MedMol) S83037-500mg ≥98% ¥3700.00元 8 - - - EA 加入購物車
大包裝詢價

提交您的電話號碼并同意《個人信息授權(quán)與保護申明》,到貨后將短信提示。
提交

產(chǎn)品介紹

參考文獻

質(zhì)檢證書(COA)

摩爾濃度計算器

相關(guān)產(chǎn)品

  • 提示:詳情請下載說明書。
  • 產(chǎn)品描述: Ribociclib (LEE011) succinate (Kisqali) 是一種高度特異性的針對 CDK4 和 CDK6 的雙重抑制劑,對應的IC50值分別為10 nM和39 nM。
  • 靶點: CDK4(Cell-free assay):10 nM;CDK6(Cell-free assay):39 nM;CDK
  • 體內(nèi)研究:
    LEE011 (200 mg/kg daily, p.o.) significantly causes tumor growth delay in mice harboring the BE2C or 1643 xenografts with no weight loss or other signs of toxicity.
  • 細胞實驗: Cell lines: BE2C, IMR5, 1643, SY5Y, CHP134, SKNSH, NGP, KELLY, LAN5, NLF, NB69, SKNDZ, NBSD, NBLS, SKNFI, EBC1, SKNAS, NB16, RPE1 cell lines Concentrations: 10 μM Incubation Time: ~100 h Method: A panel of neuroblastoma cell lines, selected based upon prior demonstration of substrate adherent growth, is plated in triplicate on the Xcelligence Real-Time Cell Electronic Sensing system and treated 24 hours later with a four-log dose range of inhibitor or with a dimethyl sulfoxide (DMSO) control. Cell indexes are monitored continuously for ~100 hours, and IC50 values are determined as follows: growth curves are generated by plotting the cell index as a function of time and are normalized to the cell index at the time of treatment for a baseline cell index of 1. The area under the normalized growth curve from the time of treatment to 96 hours posttreatment is then calculated using a baseline area of 1 (the cell index at the time of treatment). Areas are normalized to the DMSO control, and the resulting data ar
  • 動物實驗: Animal Models: Mice bearing BE2C, NB-1643, or EBC1 xenografts Dosages: ~200 mg/kg daily Administration: p.o.
  • 參考文獻:
    1. Todd VanArsdale, et al. Clin Cancer Res. 2015 Jul 1;21(13):2905-10. 2. Rader J, et al. Clin Cancer Res. 2013, 19(22), 6173-6182. 3. Antonio Marra, Giuseppe Curigliano. NPJ Breast Cancer. 2019 Aug 29;5:27.
  • 溶解性: Soluble  in  DMSO
  • 保存條件: -20°C;充氬
  • 配置溶液濃度參考:
    1mg 5mg 10mg
    1 mM 1.81 ml 9.048 ml 18.095 ml
    5 mM 0.362 ml 1.81 ml 3.619 ml
    10 mM 0.181 ml 0.905 ml 1.81 ml
    50 mM 0.036 ml 0.181 ml 0.362 ml
  • 注意:部分產(chǎn)品我司僅能提供部分信息,我司不保證所提供信息的權(quán)威性,僅供客戶參考交流研究之用。
輸入產(chǎn)品批號:

本計算器可幫助您計算出特定溶液中溶質(zhì)的質(zhì)量、溶液濃度和體積之間的關(guān)系,公式為:


質(zhì)量 (mg) = 濃度 (mM) x 體積 (mL) x 分子摩爾量 (g/mol)


  • =
    *
    *


源葉所有產(chǎn)品僅用作科學研究,銷售產(chǎn)品行為均適用于我司網(wǎng)上所列通用銷售條款。